MSQ
LAA
Laboratory Animal Allergy
Medical Surveillance Questionnaire for Lab Animal Allergies
Starting at
Page Sections
UNDERSTANDING
What is MSQ:LAA?
A specialized medical surveillance questionnaire designed to identify laboratory workers at risk from animal allergen exposure and prevent progression to permanent respiratory disability.
Purpose
To identify workers developing allergic sensitization before progression to occupational asthma and permanent disability
Audience
Laboratory workers with potential exposure to animal allergens in research, pharmaceutical, and biotechnology facilities
LABORATORY HAZARDS
The Challenge
How do research institutions protect workers when 75% don't know their LAA rates and surveillance practices vary widely?
Without standardized surveillance, institutions cannot identify at-risk workers early enough to prevent permanent disability and regulatory exposure.
Limited Options
Few specialized providers, no standards
Few specialized providers
Limited access to expertise
No standardized protocols
Inconsistent protection levels
University-only availability
Geographic and cost barriers
Manual assessment processes
Delays in worker protection
Lack of regulatory guidance
Uncertain compliance status
Proxima Solution
Evidence-based LAA surveillance platform
Expert-developed protocols
Nationally accessible expertise
Standardized assessment
Consistent worker protection
Digital platform access
No geographic limitations
Instant online completion
Immediate protection status
OSHA-aligned framework
Clear compliance pathway
PROACTIVE MONITORING
The Answer
Proxima Protection Platform delivers specialized LAA surveillance based on cutting-edge research
Our solution combines LAA research co-authored by Dr. Martin with digital technology to deliver evidence-based, accessible, and comprehensive medical surveillance for laboratory animal workers.
Led by Dr. Bill Martin
LAA Research Co-Author & National Study Leader
Our platform is medically directed by Dr. Bill Martin, an occupational medicine specialist who co-authored the landmark national study of 141 institutions and 58,224 laboratory workers published in JOEM (2023).
LAA Research Leadership
Duke University Division of Occupational & Environmental Medicine
Chief Medical Officer at Proxima & Global Medical Director for Fortune 500 companies
Occupational medicine specialist with focus on workplace respiratory hazards
Co-authored national LAA study published in Journal of Occupational & Environmental Medicine (2023)
Expert in evidence-based workplace surveillance protocols
Extensive experience in occupational allergy prevention programs
Why Choose Proxima
Medical Excellence
Built on Dr. Martin's occupational medicine expertise and evidence-based protocols
Early Detection
Identify at-risk workers as soon as possible with the goal of preventing progression to permanent disability.
Evidence-Based
Proven surveillance protocols that reduce sensitization by 68%
Specialized Access
Expert LAA surveillance available 24/7 to research institutions
Research Worker Protection
COMPLIANCE
Regulatory Landscape
Laboratory Animal Allergy affects 11-44% of research workers, yet 75% of institutions don't know their actual rates.
Without specific OSHA standards, research institutions must demonstrate evidence-based protection under the General Duty Clause and NIOSH Alert recommendations.
01OSHA General Duty Clause applies
Employers must provide a workplace "free from recognized hazards" that could cause death or serious physical harm, including known occupational allergens like laboratory animal proteins.
OSHA General Duty Clause applies
Employers must provide a workplace "free from recognized hazards" that could cause death or serious physical harm, including known occupational allergens like laboratory animal proteins.
Proxima Solution
MSQ:LAA surveillance demonstrates proactive hazard recognition and worker protection, providing regulatory defense through documented due diligence.
02NIOSH Alert 1998
NIOSH recommends comprehensive programs including medical surveillance to prevent asthma associated with laboratory animal work.
NIOSH Alert 1998
NIOSH recommends comprehensive programs including medical surveillance to prevent asthma associated with laboratory animal work.
Proxima Solution
Our platform incorporates NIOSH Alert recommendations with Dr. Martin's latest research for comprehensive surveillance protocols.
03Research-Backed Standards
Research co-authored by Dr. Martin shows comprehensive programs can reduce sensitization from 25.6% to 8.2%, with mandatory respiratory protection achieving near-zero symptomatic allergies.
Research-Backed Standards
Research co-authored by Dr. Martin shows comprehensive programs can reduce sensitization from 25.6% to 8.2%, with mandatory respiratory protection achieving near-zero symptomatic allergies.
Proxima Solution
Platform incorporates proven prevention strategies from peer-reviewed research, including optimal surveillance timing and risk stratification.
04Surveillance Documentation
Institutions need documented medical surveillance programs to demonstrate compliance with general duty obligations and evidence-based practices.
Surveillance Documentation
Institutions need documented medical surveillance programs to demonstrate compliance with general duty obligations and evidence-based practices.
Proxima Solution
Automated documentation and audit trails provide comprehensive records for regulatory inspections and compliance verification.
MEDICAL PROCESS
Medical Surveillance Process
LAA surveillance requires specialized expertise in occupational immunology and research environments
Each assessment demands occupational immunology expertise, animal allergen exposure evaluation, and comprehensive health screening. Our platform brings Dr. Martin's LAA research expertise to every digital surveillance.
Dr. Bill Martin, Chief Medical Officer
Our platform is medically directed by Dr. Bill Martin, an occupational medicine specialist who co-authored the landmark national study of 141 institutions and 58,224 laboratory workers published in JOEM (2023).
Animal Exposure Assessment
Evaluation of animal species contact, work tasks, and protective equipment use in laboratory environments
OSHA Hazard Alert Response
Expert guidance on compliance with OSHA's Hazard Alert Letter requirements and General Duty Clause enforcement strategies
Early Detection Protocol
Proactive surveillance methodology designed to identify at-risk workers before symptom progression to permanent respiratory disability
Evidence-Based LAA Assessment
MSQ:LAA incorporates Dr. Martin's research findings with occupational medicine best practices for laboratory animal allergy surveillance.
Species and Contact Assessment
Early Detection Screening
Facility Risk Assessment
Susceptibility Factors
Medical Surveillance Records
Research institutions should maintain LAA surveillance records to demonstrate due diligence in worker protection and regulatory compliance.
Medical surveillance records should be retained for duration of employment plus 30 years
Records demonstrate proactive worker protection for regulatory inspections
Employee access to surveillance records supports informed career decisions
Proper record-keeping supports institutional defense of evidence-based protection programs